Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jul;42(1):21–25. doi: 10.1038/bjc.1980.198

Cytolysis of fibroblasts by C3a.

A Temple, A C Allison
PMCID: PMC2010458  PMID: 7426327

Abstract

C3a was found to be more cytolytic to transformed than to primary fibroblast cultures from mouse and man. Fibroblasts made quiescent with caffeine were lysed by the same concentrations of C3a as untreated cells. These findings may have implications in tumour immunity.

Full text

PDF
21

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bentley C., Bitter-Suermann D., Hadding U., Brade V. In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages. Eur J Immunol. 1976 Jun;6(6):393–398. doi: 10.1002/eji.1830060604. [DOI] [PubMed] [Google Scholar]
  2. Bitter-Suermann D., Hadding U., Melchert F., Wellensiek H. J. Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. Immunochemistry. 1970 Dec;7(12):955–965. doi: 10.1016/0019-2791(70)90002-9. [DOI] [PubMed] [Google Scholar]
  3. Bokisch V. A., Müller-Eberhard H. J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest. 1970 Dec;49(12):2427–2436. doi: 10.1172/JCI106462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cochrane C. G., Müller-Eberhard H. J. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med. 1968 Feb 1;127(2):371–386. doi: 10.1084/jem.127.2.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ferluga J., Schorlemmer H. U., Baptista L. C., Allison A. C. Cytolytic effects of the complement cleavage product, C3a. Br J Cancer. 1976 Dec;34(6):626–634. doi: 10.1038/bjc.1976.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferluga J., Schorlemmer H. U., Baptista L. C., Allison A. C. Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. Clin Exp Immunol. 1978 Mar;31(3):512–517. [PMC free article] [PubMed] [Google Scholar]
  7. Goodman M. G., Weigle W. O., Hugli T. E. Inability of the C3a anaphylatoxin to promote cellular lysis. Nature. 1980 Jan 3;283(5742):78–80. doi: 10.1038/283078a0. [DOI] [PubMed] [Google Scholar]
  8. Lai A Fat R. F., van Furth R. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology. 1975 Feb;28(2):359–368. [PMC free article] [PubMed] [Google Scholar]
  9. Nicholson A., Brade V., Schorlemmer H. U., Burger R., Bitter-Suermann D., Hadding U. Interaction of C3b, B, and D in the alternative pathway of complement activation. J Immunol. 1975 Oct;115(4):1108–1113. [PubMed] [Google Scholar]
  10. Nicolson G. L. Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy. Biochim Biophys Acta. 1976 Apr 30;458(1):1–72. doi: 10.1016/0304-419x(76)90014-7. [DOI] [PubMed] [Google Scholar]
  11. Pardee A. B., James L. J. Selective killing of transformed baby hamster kidney (BHK) cells. Proc Natl Acad Sci U S A. 1975 Dec;72(12):4994–4998. doi: 10.1073/pnas.72.12.4994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schorlemmer H. U., Allison A. C. Effects of activated complement components on enzyme secretion by macrophages. Immunology. 1976 Nov;31(5):781–788. [PMC free article] [PubMed] [Google Scholar]
  13. Schorlemmer H. U., Davies P., Allison A. C. Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature. 1976 May 6;261(5555):48–49. doi: 10.1038/261048a0. [DOI] [PubMed] [Google Scholar]
  14. Wuepper K. D., Bokisch V. A., Müller-Eberhard H. J., Stoughton R. B. Cutaneous responses to human C 3 anaphylatoxin in man. Clin Exp Immunol. 1972 May;11(1):13–20. [PMC free article] [PubMed] [Google Scholar]
  15. da Silva W. D., Eisele J. W., Lepow I. H. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3. J Exp Med. 1967 Dec 1;126(6):1027–1048. doi: 10.1084/jem.126.6.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES